FDA inspection
USL Pharma Inc. dba Upsher-Smith Laboratories, LLC: FDA inspection ending Jan 24, 2019
FDA inspection 1080819 · No Action Indicated (NAI) · Denver, CO
Key facts
| Inspection ID | 1080819 |
|---|---|
| Firm | USL Pharma Inc. dba Upsher-Smith Laboratories, LLC |
| FEI number | 1719991 |
| Address | 301 S Cherokee St |
| City | Denver |
| State | CO |
| ZIP | 80223-2114 |
| Fiscal year | 2019 |
| Inspection end date | Jan 24, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data